|
循环肿瘤细胞对结直肠癌临床诊疗的研究进展
|
Abstract:
近年来全球结直肠癌的发病率和死亡率均呈明显增长。结直肠癌在确诊时,大部分已是中晚期,治疗效果及患者的预后均不理想;现阶段临床上诊断结直肠癌还是依靠肿瘤标记物的监测以及CT、MRI、结肠镜等影像学检查,这些检查或灵敏度欠佳,或对患者自身创伤较大,或是不能随时监测疾病进展。有研究显示循环肿瘤细胞可用于诊断早期结直肠癌、评估结直肠癌诊疗效果以及监测癌症转移和预后等。笔者就循环肿瘤细胞对结直肠癌临床诊疗的全球研究进展作了综述,这对临床参考价值极大。
In recent years, the incidence and mortality of colorectal cancer have increased significantly world-wide. When colorectal cancer is diagnosed, most of it is in the middle and advanced stage, and the treatment effect and prognosis of patients are not ideal. At the present stage, the clinical diagnosis of colorectal cancer still relies on the monitoring of tumor markers and imaging examinations such as CT, MRI and colonoscopy. These examinations are not sensitive enough, or have great trauma to the patients themselves, or cannot monitor the progress of the disease at any time. Studies have shown that circulating tumor cells can be used to diagnose early colorectal cancer, evaluate the therapeutic effect of colorectal cancer, and monitor cancer metastasis and prognosis. This paper re-views the global research progress of circulating tumor cells in clinical diagnosis and treatment of colorectal cancer, which has great clinical reference value.
[1] | Jiayi, H. and Lei, C. (2021) Research Progress of Intestinal Flora Imbalance and Colorectal Cancer. Translational Medi-cine Journal, 10, 4. |
[2] | Hu, M., Wang, Z., Wu, Z., Ding, P., Pei, R., Wang, Q. and Xing, C. (2021) Circulating Tumor Cells in Colorectal Cancer in the Era of Precision Medicine. Journal of Molecular Medicine (Berlin), 100, 197-213.
https://doi.org/10.1007/s00109-021-02162-3 |
[3] | 孙可欣, 郑荣寿, 张思维, 曾红梅, 邹小农, 陈茹, 顾秀瑛, 魏文强, 赫捷. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. |
[4] | Amin, M.B., Greene, F.L., Edge, S., Compton, C.C., Gershenwald, J.E., Brookland, R.K., Meyer, L., Gress, D.M., Byrd, D.R. and Winchester, D.P. (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to Build a Bridge from a Popula-tion-Based to a More “Personalized” Approach to Cancer Staging. CA: A Cancer Journal for Clinicians, 67, 93-99. https://doi.org/10.3322/caac.21388 |
[5] | Heidrich, I., Abdalla, T.S.A., Reeh, M. and Pantel, K. (2021) Clinical Ap-plications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer. Cancers (Basel), 13, 4500.
https://doi.org/10.3390/cancers13184500 |
[6] | Lu, G., Lu, Z., Li, C., Huang, X. and Luo, Q. (2021) Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy. Computational and Mathematical Methods in Medicine, 2021, Article ID: 2294562.
https://doi.org/10.1155/2021/2294562 |
[7] | Ferreira, M.M., Ramani, V.C. and Jeffrey, S.S. (2016) Circulating Tu-mor Cell Technologies. Molecular Oncology, 10, 374-394. https://doi.org/10.1016/j.molonc.2016.01.007 |
[8] | Das, A., Kunkel, M., Joudeh, J., et al. (2015) Clinico-Pathological Correlation of Serial Measurement of Circulating Tumor Cells in 24 Metastatic Colorectal Cancer Patients Receiving Chemotherapy Reveals Interpatient Heterogeneity Correlated with Ca Levels But Independent of Kras and Braf Mutation. Cancer Biology & Therapy, 16, 709-713.
https://doi.org/10.1080/15384047.2015.1030555 |
[9] | Vu, T. and Datta, P.K. (2017) Regulation of EMT in Colo-rectal Cancer: A Culprit in Metastasis. Cancers (Basel), 9, 171-192. https://doi.org/10.3390/cancers9120171 |
[10] | Friedlander, T.W., Premasekharan, G. and Paris, P.L. (2014) Looking Back to the Future of Circulating Tumor Cells. Pharmacology & Therapeutics, 142, 271-280. https://doi.org/10.1016/j.pharmthera.2013.12.011 |
[11] | Alix-Panabières, C. and Pantel, K. (2021) Liquid Biopsy: From Discovery to Clinical Application. Cancer Discovery, 11, 858-873. https://doi.org/10.1158/2159-8290.CD-20-1311 |
[12] | Balcik-Ercin, P., Cayrefourcq, L., Soundararajan, R., Mani, S.A. and Alix-Panabières, C. (2021) Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer. Cancers (Basel), 13, 5408. https://doi.org/10.3390/cancers13215408 |
[13] | Tsai, W.S., You, J.F., Hung, H.Y., Hsieh, P.S., Hsieh, B., Lenz, H.J., Idos, G., Friedland, S., Yi-Jiun Pan, J., Shao, H.J., Wu, J.C., Lai, J.M., Chang, S.E., Mei, R., Watson, D., Javey, M. and Nimgaonkar, A. (2019) Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer. Clinical and Translational Gastroenterology, 10, e00088. https://doi.org/10.14309/ctg.0000000000000088 |
[14] | 胡茜玥, 刘正, 王锡山. 结直肠癌筛查策略的研究现状与思考[J]. 中国全科医学, 2021, 24(33): 4165-4171. |
[15] | 张波, 谢良军, 江波, 等. 循环肿瘤细胞计数在辅助诊断结直肠癌中的应用价值[J]. 中华消化杂志, 2017, 37(10): 679-683. https://doi.org/10.3760/cma.j.issn.0254-1432.2017.10.007 |
[16] | Wensy, T., Ashish, N., Oscar, S., et al. (2018) Prospective Clinical Study of Circulating Tumor Cells for Colorectal Cancer Screening. Journal Clinical Oncolo-gy, 36, 556. https://doi.org/10.1200/JCO.2018.36.4_suppl.556 |
[17] | 李贵, 赵建波, 胡桂明, 等. 不同分期结直肠癌患者循环肿瘤细胞的表达及临床意义[J]. 临床心身疾病杂志, 2020, 26(3): 6-10. https://doi.org/10.3969/j.issn.1672-187X.2020.03.002 |
[18] | 蒋晓芬, 邵传锋, 张浩, 杨丽娟, 王中林, 潘杰, 吴伟. 循环肿瘤细胞联合癌胚抗原检测在I、II期结直肠癌诊断中的应用研究[J]. 中华全科医学, 2018, 16(10): 1653-1655. |
[19] | 杨朝美, 冯杰, 郎磊, 颜光涛. CTC、CEA、CA125联合检测在结直肠癌中的临床价值[J]. 检验医学, 2021, 36(9): 901-905. |
[20] | 黄选章, 王振宁. 循环肿瘤细胞在结直肠癌化疗中意义的Meta分析[C]//中国抗癌协会胃癌专业委员会. 第9届全国胃癌学术会议暨第二届阳光长城肿瘤学术会议论文汇编. 中国抗癌协会胃癌专业委员会: 中国抗癌协会, 2014: 2. |
[21] | 车凯军, 查国华, 龙剑. 循环肿瘤细胞在晚期结直肠癌化疗疗效评价的价值探讨[J]. 江西医药, 2021, 56(8): 1147-1149. |
[22] | Chen, C.J., Sung, W.W., Chen, H.C., Chern, Y.J., Hsu, H.T., Lin, Y.M., Lin, S.H., Peck, K. and Yeh, K.T. (2017) Early Assessment of Colorectal Cancer by Quantifying Cir-culating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer. International Journal of Molecular Sciences, 18, 743. https://doi.org/10.3390/ijms18040743 |
[23] | Aggarwal, C. and Meropol, N.J. (2013) Relationship among Circulating Tumor Cells, CEA and Overall Survival in Patients with Meta-Static Colorectal Cancer. Annals of Oncology, 24, 420-428. https://doi.org/10.1093/annonc/mds336 |
[24] | 曹霞, 吴伟, 赵小玉, 李曾, 韩亚兵, 李翔, 田姗, 张丹. 早中期结直肠癌手术前后外周血循环肿瘤细胞的监测及预后分析[J]. 中山大学学报(医学版), 2019, 40(4): 604-614. |
[25] | 刘之林, 张成武. 进展期胃癌腹腔种植转移的研究进展[J]. 中国肿瘤外科杂志, 2020, 12(3): 271-275. |
[26] | 汪栋, 金岚, 王今, 白志刚, 王婷婷, 丁国乾, 杨盈赤, 姚宏伟, 张忠涛. II-III期结直肠癌病人围手术期外周血循环肿瘤细胞检测及其临床意义[J]. 中国实用外科杂志, 2019, 39(4): 361-364. |
[27] | Liu, H., Zhang, X., Li, J., Sun, B., Qian, H. and Yin, Z. (2015) The Biological and Clinical Importance of Epithelial-Mesenchymal Tran-sition in Circulating Tumor Cells. Journal of Cancer Research and Clinical Oncology, 141, 189-201. https://doi.org/10.1007/s00432-014-1752-x |
[28] | Zhong, Y., Ma, T., Qiao, T., Hu, H. Li, Z., Luo, K., Wang, Y., Tang, Q., Wang, G., Huang, R. and Wang, X. (2021) Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer. Cancer Management and Research, 13, 7077-7085. https://doi.org/10.2147/CMAR.S316544 |
[29] | Hou, J., Guo, C. and Lyu, G. (2020) Clinical Significance of Epithe-lial-Mesenchymal Transition Typing of Circulating Tumour Cells in Colorectal Cancer. Colorectal Disease, 22, 581-587. https://doi.org/10.1111/codi.14927 |
[30] | Wu, F., Zhu, J., Mao, Y., Li, X., Hu, B. and Zhang, D. (2017) Associa-tions between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer. Disease Markers, 2017, Article ID: 9474532. https://doi.org/10.1155/2017/9474532 |